Skip to main content
Premium Trial:

Request an Annual Quote

NetGenics Lands Contract to Build Schering s Company-wide Gene Database

NEW YORK, June 11 - NetGenics has been selected by Schering AG to build a corporate-wide gene database, the company announced on Monday.

The database will link worldwide R&D efforts for Berlin-based Schering by providing a single point of access to curated and annotated gene, sequence, and expression data, according to NetGenics.

Financial terms of the agreement were not disclosed.

The system will be custom built for Schering and will include technology from NetGenics Component Library and IBM's DiscoveryLink, which NetGenics is authorized to distribute as part of an agreement made with IBM in April.

"Schering AG has a unique set of needs and we're excited about working with them to help solve their specific problems," NetGenics vice president of solutions development Richard Resnick said in a statement. "This project represents an important development effort for NetGenics, as it allows us to bring our considerable software and scientific component-base to bear on a distinct customer need."

In January, NetGenics laid off 29 people, cutting its workforce by nearly 30 percent. The company attributed the layoffs to its stalled initial public offering. NetGenics CEO Manuel Glynias said at the time that the company had "enough cash for at least a year" and did not intend to raise more money privately.


The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.